z-logo
open-access-imgOpen Access
Gemtuzumab ozogamicin in acute myeloid leukemia: act 2, with perhaps more to come
Author(s) -
Johann Hitzler,
Elihu H. Estey
Publication year - 2018
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2018.205948
Subject(s) - gemtuzumab ozogamicin , myeloid leukemia , calicheamicin , medicine , leukemia , oncology , cd33 , biology , genetics , stem cell , cd34

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here